These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26715378)

  • 1. Exploring the role and function of trial steering committees: results of an expert panel meeting.
    Harman NL; Conroy EJ; Lewis SC; Murray G; Norrie J; Sydes MR; Lane JA; Altman DG; Baigent C; Bliss JM; Campbell MK; Elbourne D; Evans S; Sandercock P; Gamble C
    Trials; 2015 Dec; 16():597. PubMed ID: 26715378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cohort examination to establish reporting of the remit and function of Trial Steering Committees in randomised controlled trials.
    Conroy EJ; Arch B; Harman NL; Lane JA; Lewis SC; Norrie J; Sydes MR; Gamble C
    Trials; 2017 Dec; 18(1):590. PubMed ID: 29221458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Issues in data monitoring and interim analysis of trials.
    Grant AM; Altman DG; Babiker AB; Campbell MK; Clemens FJ; Darbyshire JH; Elbourne DR; McLeer SK; Parmar MK; Pocock SJ; Spiegelhalter DJ; Sydes MR; Walker AE; Wallace SA;
    Health Technol Assess; 2005 Mar; 9(7):1-238, iii-iv. PubMed ID: 15763038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What are the roles and valued attributes of a Trial Steering Committee? Ethnographic study of eight clinical trials facing challenges.
    Daykin A; Selman LE; Cramer H; McCann S; Shorter GW; Sydes MR; Gamble C; Macefield R; Lane JA; Shaw A
    Trials; 2016 Jul; 17(1):307. PubMed ID: 27369866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative.
    Calis KA; Archdeacon P; Bain R; DeMets D; Donohue M; Elzarrad MK; Forrest A; McEachern J; Pencina MJ; Perlmutter J; Lewis RJ
    Clin Trials; 2017 Aug; 14(4):342-348. PubMed ID: 28503947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A third trial oversight committee: Functions, benefits and issues.
    Lane JA; Gamble C; Cragg WJ; Tembo D; Sydes MR
    Clin Trials; 2020 Feb; 17(1):106-112. PubMed ID: 31665920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'We all want to succeed, but we've also got to be realistic about what is happening': an ethnographic study of relationships in trial oversight and their impact.
    Daykin A; Selman LE; Cramer H; McCann S; Shorter GW; Sydes MR; Gamble C; Macefield R; Lane JA; Shaw A
    Trials; 2017 Dec; 18(1):612. PubMed ID: 29273060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A major trial needs three statisticians: why, how and who?
    Pocock SJ
    Stat Med; 2004 May; 23(10):1535-9. PubMed ID: 15122734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formalising the induction of patient and public involvement contributors on trial oversight committees.
    Pickering EC; Hanley B; Bell P; Gath J; Hanlon P; Oldroyd R; Stephens R; Tweed CD
    Res Involv Engagem; 2021 Jun; 7(1):42. PubMed ID: 34140027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should statisticians reporting to data monitoring committees be independent of the trial sponsor and leadership?
    Ellenberg SS; George SL
    Stat Med; 2004 May; 23(10):1503-5. PubMed ID: 15122727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the functions and operations of data monitoring committees: Survey and focus group findings.
    Calis KA; Archdeacon P; Bain RP; Forrest A; Perlmutter J; DeMets DL
    Clin Trials; 2017 Feb; 14(1):59-66. PubMed ID: 27885056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trial Steering Committees in randomised controlled trials: A survey of registered clinical trials units to establish current practice and experiences.
    Conroy EJ; Harman NL; Lane JA; Lewis SC; Murray G; Norrie J; Sydes MR; Gamble C
    Clin Trials; 2015 Dec; 12(6):664-76. PubMed ID: 26085545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing trial integrity by protecting the independence of data monitoring committees in clinical trials.
    Fleming TR; Hennekens CH; Pfeffer MA; DeMets DL
    J Biopharm Stat; 2014; 24(5):968-75. PubMed ID: 24926941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding and optimising patient and public involvement in trial oversight: an ethnographic study of eight clinical trials.
    Coulman KD; Nicholson A; Shaw A; Daykin A; Selman LE; Macefield R; Shorter GW; Cramer H; Sydes MR; Gamble C; Pick ME; Taylor G; Lane JA
    Trials; 2020 Jun; 21(1):543. PubMed ID: 32552907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Issues in regulatory guidelines for data monitoring committees.
    DeMets D; Califf R; Dixon D; Ellenberg S; Fleming T; Held P; Julian D; Kaplan R; Levine R; Neaton J; Packer M; Pocock S; Rockhold F; Seto B; Siegel J; Snapinn S; Stump D; Temple R; Whitley R
    Clin Trials; 2004; 1(2):162-9. PubMed ID: 16281888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ESHRE guideline: endometriosis.
    Becker CM; Bokor A; Heikinheimo O; Horne A; Jansen F; Kiesel L; King K; Kvaskoff M; Nap A; Petersen K; Saridogan E; Tomassetti C; van Hanegem N; Vulliemoz N; Vermeulen N;
    Hum Reprod Open; 2022; 2022(2):hoac009. PubMed ID: 35350465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the independence of data monitoring committee in adaptive design clinical trials.
    Chow SC; Corey R; Lin M
    J Biopharm Stat; 2012; 22(4):853-67. PubMed ID: 22651119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "You have to keep your nerve on a DMC." Challenges for Data Monitoring Committees in neonatal intensive care trials: Qualitative accounts from the BRACELET Study.
    Snowdon C; Brocklehurst P; Tasker RC; Ward Platt M; Elbourne D
    PLoS One; 2018; 13(7):e0201037. PubMed ID: 30048484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Data and safety monitoring boards: academic credit where credit is due?
    Armstrong PW; Califf RM
    JAMA; 2013 Oct; 310(15):1563-4. PubMed ID: 24129461
    [No Abstract]   [Full Text] [Related]  

  • 20. Independence of the statistician who analyses unblinded data.
    Siegel JP; O'Neill RT; Temple R; Campbell G; Foulkes MA
    Stat Med; 2004 May; 23(10):1527-9. PubMed ID: 15122732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.